Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa.
Rosenthal PJ, Asua V, Conrad MD.
Nat Rev Microbiol. 2024 Jun;22(6):373-384. doi: 10.1038/s41579-024-01008-2. Epub 2024 Feb 6.
Tetracyclines in malaria.
Gaillard T, Madamet M, Pradines B.
Malar J. 2015 Nov 10;14:445. doi: 10.1186/s12936-015-0980-0.
Antimalarial drug resistance and early drug discovery.
Garcia-Bustos JF, Gamo FJ.
Curr Pharm Des. 2013;19(2):270-81.
Antimalarial pyrido[1,2-a]benzimidazoles.
Ndakala AJ, Gessner RK, Gitari PW, October N, White KL, Hudson A, Fakorede F, Shackleford DM, Kaiser M, Yeates C, Charman SA, Chibale K.
J Med Chem. 2011 Jul 14;54(13):4581-9. doi: 10.1021/jm200227r. Epub 2011 Jun 16.
Tafenoquine: First Global Approval.
Frampton JE.
Drugs. 2018 Sep;78(14):1517-1523. doi: 10.1007/s40265-018-0979-2.
Identifying Fast and Slow-Acting Antimalarial Compounds of Pandemic Response Box Against Blood-Stage Culture of Plasmodium falciparum 3D7.
Rajendran V, Naveen NC.
Curr Microbiol. 2024 Jan 30;81(3):81. doi: 10.1007/s00284-023-03601-9.
Discovery of Potent and Fast-Acting Antimalarial Bis-1,2,4-triazines.
Priebbenow DL, Mathiew M, Shi DH, Harjani JR, Beveridge JG, Chavchich M, Edstein MD, Duffy S, Avery VM, Jacobs RT, Brand S, Shackleford DM, Wang W, Zhong L, Lee G, Tay E, Barker H, Crighton E, White KL, Charman SA, De Paoli A, Creek DJ, Baell JB.
J Med Chem. 2021 Apr 8;64(7):4150-4162. doi: 10.1021/acs.jmedchem.1c00044. Epub 2021 Mar 24.
The treatment of malaria.
White NJ.
N Engl J Med. 1996 Sep 12;335(11):800-6. doi: 10.1056/NEJM199609123351107.
Recent Advances in the Development of Chemotherapeutic Agents for Malaria.
Shrivastava N, Khan SA, Ahmad S, Al-Balushi K, Husain A.
Mini Rev Med Chem. 2021;21(12):1487-1508. doi: 10.2174/1389557521666201221161750.
Plasmodium falciparum: multifaceted resistance to artemisinins.
Paloque L, Ramadani AP, Mercereau-Puijalon O, Augereau JM, Benoit-Vical F.
Malar J. 2016 Mar 9;15:149. doi: 10.1186/s12936-016-1206-9.
